Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0403608 (
ureter
)
9,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous studies have indicated that macrophage phenotype diversity is involved in the progression of renal fibrosis. However, the factors facilitating M1 or M2 phenotypes and the function of these polarized macrophages in kidney injury and fibrosis remain largely unknown. In the present study, we found that macrophages accumulated in the kidney interstitium exhibited mainly as the M1 phenotype at the early stage of unilateral ureter obstruction (UUO).
High-mobility group box 1
(
HMGB1
) protein expressed and released from tubular epithelial cells and interstitial macrophages was essential for the M1 macrophage transition.
HMGB1
significantly induced the expression of the M1 marker inducible nitric oxide synthase while decreasing the M2 marker IL-10 in macrophages. Moreover, a glycyrrhizic acid derivative, a blocker of
HMGB1
release, reduced UUO-mediated kidney injury and ameliorated UUO-induced renal fibrosis. Interestingly and importantly, UUO caused a low pH value in the urine accumulated in the obstructed
ureter
, and the acidified urine induced
HMGB1
release from tubular epithelial cells and macrophages in vitro. Our data demonstrate that
HMGB1
is an essential contributor in facilitating M1 polarization at the early stage of UUO. Inhibition of
HMGB1
release may alter macrophage phenotype and contribute to the protection of kidney tissue from injury and fibrosis.
...
PMID:HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury. 2537 11